Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.52 |
| ▸ | ITGAV | P06756 | 18/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 11/20 | 0.52 |
| ▸ | GCGR | P47871 | 2/20 | 0.35 |
| ▸ | GIPR | P48546 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7464513 | 0.87 | ITGB3 (0.58) | ITGB3ITGAVITGA2B | |
| SCHEMBL7461018 | 0.84 | ITGB3 (0.57) | ITGB3ITGAVITGA2B | |
| SCHEMBL7052828 | 0.84 | ITGB3 (0.76) | ITGB3ITGAVITGA2B | |
| SCHEMBL6793124 | 0.84 | ITGB3 (0.71) | ITGB3ITGAVITGA2B | |
| SCHEMBL7461955 | 0.83 | ITGB3 (0.75) | ITGB3ITGAVITGA2B | |
| SCHEMBL7459020 | 0.82 | ALDH1A1 (0.38) | ITGB3ITGAVITGA2BGCGRGIPR | |
| SCHEMBL7459950 | 0.82 | ITGB3 (0.56) | ITGB3ITGAVITGA2B | |
| SCHEMBL7474768 | 0.81 | ITGB3 (0.72) | ITGB3ITGAVITGA2B | |
| SCHEMBL382414 | 0.81 | ITGB3 (0.77) | ITGB3ITGAVITGA2B | |
| SCHEMBL7049845 | 0.81 | ITGB3 (0.74) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1227083-A1 | 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS | MEIJI SEIKA KAISHA LTD. (JP) | 2002-07-31 | — | — | EP | claimed |
| EP-1227083-A1 | 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS | MEIJI SEIKA KAISHA LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |